Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022
Year: 2024
Type: article
Study design: Clinical Trial
DOI: 10.17615/45rg-jh61
Authors: Melisko, M.E., Santa-Maria, C.A., Nangia, J.R., Smith, K.L., Moy, B., Brufsky, A.M., Cotter, C., Trapani, D., Tayob, N., Lin, N.U., Pereslete, A.M., Freedman, R.A., Davis, R., Chen, W.Y., Burns, R.T., Rauf, Y., Wolff, A.C., Parsons, H.A., Savoie, J., Ashai, N., Krop, I.E., O’Sullivan, C.C., Van Poznak, C., Rimawi, M.F., DeMeo, M.K., Heiling, H.M., Winer, E.P., Li, T.
Institution: University of North Carolina at Chapel Hill
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4403284220